Jose Andres R. I.
- Country
- Spain
- Department
- Rheumatology Service
Research Overview
- Phase II Randomized Study to Evaluate the Efficacy and Safety of AZD1163 in Participants with Moderately-to-Severely Active Rheumatoid Arthritis
- Phase 2b Study of Tulisokibart in Participants With Psoriatic Arthritis
- Open-Label, Single-Arm 52‑Week Study of Subcutaneous Anifrolumab 120 mg Weekly in Immunosuppressant‑Naïve and Biologic‑Naïve Systemic Lupus Erythematosus Patients
Data & Insights
Has run more than one trial at 195 of 417 partner sites.
Specializations
Autoimmune Rheumatic Conditions
This investigator specializes in treating various autoimmune rheumatic disorders, with particular focus on Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis. Their research extends to innovative therapies for Psoriatic Arthritis and Axial Spondyloarthritis.
- Lupus management approaches
- Rheumatoid arthritis therapies
- Psoriatic arthritis treatments
Systemic Autoimmune Diseases
The investigator has extensive experience in treating complex systemic conditions including Sjögren's Syndrome and Systemic Sclerosis. Their work includes studies on interstitial lung disease associated with systemic sclerosis.
- Sjögren's syndrome therapies
- Systemic sclerosis treatments
- Autoimmune lung complications
Vascular and Inflammatory Disorders
Research interests include the treatment of Giant Cell Arteritis and Eosinophilic Granulomatosis with Polyangiitis. The investigator focuses on developing therapeutic approaches for these rare but severe conditions.
- Vasculitis treatment approaches
- Inflammatory vascular conditions
- Novel therapeutic strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.